Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome Low Risk
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to MDS
Related studies linked through entity extraction aliases.
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
- Status
- TERMINATED
- Phase
- PHASE3
A Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 and/or Ras Mutations
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of LDE255 in Combination With Azacitidine for High Risk Myelodysplastic Syndrome Patients
- Status
- COMPLETED
- Phase
- PHASE1
Ultra-Low Dose IL-2 Therapy as GVHD Prophylaxis in Haploidentical Allogeneic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
Randomized Phase III Study of Decitabine +/- Hydroxyurea (HY) Versus HY in Advanced Proliferative CMML
- Status
- COMPLETED
- Phase
- PHASE3
A Phase II Trial of SGI-110 in Patients With IPSS High and Int 2 Myelodysplastic Syndrome, Acute Myeloid Leukemia With 20-30% Marrow Blasts or Chronic Myelomonocytic Leukemia Type 2 Not Responding to Azacitidine or Decitabine After at Least 6 Courses or Relapsing After a Response
- Status
- COMPLETED
- Phase
- PHASE2
Study of FF-10501-01 in Patients With Relapsed or Refractory Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source
- Status
- COMPLETED
- Phase
- PHASE1
The Effect of Blood Transfusion on Endothelial Function
- Status
- COMPLETED
- Phase
- N/A
Pharmacokinetic Guided Dose Escalation and Dose Confirmation With Oral Decitabine and Oral Cytidine Deaminase Inhibitor (CDAi) in Patients With Myelodysplastic Syndromes (MDS)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Haplo-identical SCT for High Risk (HR) Hematologic Malignancies w/Post-Transplant In-Vivo T-cell Depletion
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Allo vs Hypomethylating/Best Supportive Care in MDS (BMTCTN1102)
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study Adding Pracinostat to a Hypomethylating Agent (HMA) in Patients With MDS Who Failed to Respond to Single Agent HMA
- Status
- COMPLETED
- Phase
- PHASE2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Combined Deferasirox, Vitamin D and Azacytidine in High Risk MDS
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Decitabine Combining Modified CAG Followed by HLA Haploidentical Peripheral Blood Mononuclear Cells Infusion for Elderly Patients With Acute Myeloid Leukemia(AML）
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Efficacy and Safety of Oral Rigosertib in Transfusion-dependent, Low or Int-1 or Trisomy 8 Int-2 Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
FLT-PET Imaging for MDS
- Status
- TERMINATED
- Phase
- NA
A Clinical Study of KRN321 in Adult Subjects With Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2